Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
Alexander Tenenbaum; Enrique Z Fisman
- 作者Alexander Tenenbaum; Enrique Z Fisman
- 卷第3卷
- 期第1期
- 印刷ISSN1475-2840
- 文件大小481.19KB
- 发表时间2004-12
- DOI10.1186/1475-2840-3-10